644 Early Mucosal Healing Status Predicts Long-Term Clinical Benefits for Adalimumab-Treated Patients with Moderate to Severe Crohn's Disease

Paul J. Rutgeerts,Walter Reinisch,Roopal Thakkar,Eric Q. Wu,Anna Kaltenboeck,Mei Yang,Parvez Mulani,Jingdong Chao
DOI: https://doi.org/10.1016/s0016-5085(10)60389-7
IF: 29.4
2010-01-01
Gastroenterology
Abstract:mice exhibited significantly less hyperplastic response to C. rodentium infection as assessed by crypt length (average iNWKO 302.8 μm ± 38.6 μm vs. WT 393.3 μm ± 116.4 μm, p= 0.02).iNWKO mice exhibited rare mucosal ulcerations, less goblet cell depletion and a milder inflammatory infiltrate compared to WT.More C. rodentium was recovered from the stool of iNWKO mice (mean iNWKO 4.7x10 5 CFU/g vs. WT 5.4x10 4 CFU/g, p=0.08) and could be isolated from the spleen (1x10 5 CFU/g) in some iNWKO, but not WT, mice 4 days after infection.No bacteria were recovered from the mesenteric lymph nodes from either WT or iNWKO mice.Conclusion: N-WASP is critical for host response to C. rodentium, and ablation of N-WASP results in attenuated mucosal hyperplasia, higher bacterial stool burden and more disseminated infection.
What problem does this paper attempt to address?